BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

bioTheranostics 

11025 Roselle Street
Suite 200
San Diego  California  92121  U.S.A.
Phone: 858-587-5870 Fax: 858-587-5871


SEARCH JOBS








 Company News
bioTheranostics Signs Agreement With National PPO Network Prime Health Services 4/9/2014 9:25:12 AM    More...
bioTheranostics’ New Biot3 Metastatic Cancer Solution Provides Comprehensive Genomic Testing With Integration Of Next Generation Sequencing 2/3/2014 12:32:39 PM    More...
bioTheranostics Signs Collaboration Agreement With Top U.S. Hospital and Reference Laboratory to Offer CancerTYPE ID® Molecular Test for Metastatic Cancer 10/29/2013 9:54:47 AM    More...
bioTheranostics’ Breast Cancer IndexSM Molecular Test Identifies Risk for Early and Late Breast Cancer Recurrence, Lancet Oncology Study Finds 9/12/2013 9:47:51 AM    More...
bioTheranostics Appoints Three Key Executives 8/27/2013 6:32:55 AM    More...
bioTheranostics is Now an In-Network Provider With Highmark Health Services for Its CancerTYPE ID® Molecular Test for Metastatic Cancer 8/1/2013 2:27:24 PM    More...
Studies Show bioTheranostics’ Breast Cancer Index℠ Identifies Breast Cancer Patients at Risk for Early and Late Recurrence, and Predicts Benefit From Extended Endocrine Therapy 7/10/2013 9:33:39 AM    More...
Studies Further Demonstrate Clinical Utility & Cost-Effectiveness of bioTheranostics’ CancerTYPE ID® Molecular Test in Metastatic Cancer 5/31/2013 3:02:31 PM    More...
Prospective Study Shows that Therapy Guided by bioTheranostics' CancerTYPE ID® Molecular Test Improves Survival in Cancer of Unknown Primary Patients 10/3/2012 10:02:19 AM    More...
bioTheranostics Adds Chief Commercial Officer & VP of Corporate Development 7/25/2012 9:44:07 AM    More...
123

//-->